Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ptc Therapeutics (PTCT) Receivables - Other: 2023-2024

Historic Receivables - Other for Ptc Therapeutics (PTCT) over the last 1 years, with Mar 2024 value amounting to $800,000.

  • Ptc Therapeutics' Receivables - Other was N/A to $800,000 in Q1 2024 from the same period last year, while for Mar 2024 it was $800,000, marking a year-over-year change of. This contributed to the annual value of $200,000 for FY2023, which is N/A change from last year.
  • Ptc Therapeutics' Receivables - Other amounted to $800,000 in Q1 2024, which was up 300.00% from $200,000 recorded in Q4 2023.
  • Ptc Therapeutics' Receivables - Other's 5-year high stood at $1.4 million during Q3 2023, with a 5-year trough of $200,000 in Q4 2023.
  • In the last 2 years, Ptc Therapeutics' Receivables - Other had a median value of $600,000 in 2023 and averaged $700,000.